Drug Delivery Systems
New drug discoveries and technologies require innovative delivery systems in order to be effective. Drug delivery describes a process where a therapeutic agent is administered to the body in a controlled manner. As scientists research and develop a pipeline of new drugs and actives, the methods of administering therapeutic drugs will change and adapt to the new environment. Over the past decade, the US drug delivery systems industry has experienced robust growth. The size for the US drug delivery systems market was estimated at about $47 Billion in 2002 and was projected to grow at an annual rate of 9% to $82 Billion by 2007. The drug delivery industry comprises about 15% of the total pharmaceutical industry and is forecasted to represent 20% of global pharmaceutical sales by the end of the decade. Strong growth opportunities are projected to extend into all therapeutic classes of pharmaceuticals.
Migami has developed and acquired a number of advanced proprietary drug delivery technologies, which can be used to create health and wellness, beauty and all natural anti-aging products with distinct competitive advantages for the Pacific Rim markets. Migami is in the process of identifying, and negotiating with, a cross-section of Pacific Rim pharmaceutical and health care companies that have taken advantage of one or more of these proprietary technologies.
Please click on each of the following hyperlinks for an in-depth discussion of each of the drug-delivery platform technologies for Migami.
|
